Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison

Aug.25.2025
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.

Key Points:

·Etomidate Classification: From September 1, etomidate will be classified as a Class C drug under Singapore's Misuse of Drugs Act.

·Health Risks: Etomidate-laced e-cigarettes, known as "zombie pods," pose serious health risks, including nausea, muscle spasms, and potential death.

·Enforcement Actions: Singapore has intensified enforcement efforts, seizing over 850 e-cigarettes and related products in recent operations.

·Legal Penalties: Users face mandatory rehabilitation and potential prosecution. Traffickers and distributors face up to 20 years in prison and caning.

·Tourism Impact: Local tour guides and travel agencies are informing tourists about the new regulations to ensure compliance and avoid penalties.

 


 

According to reports from various media outlets, including Lianhe Zaobao and 8world, Singapore will classify the anesthetic etomidate as a Class C drug from Sept. 1. Traffickers and users may face prosecution and a minimum one-year jail term.

 

Etomidate, mixed into e-cigarettes, is widely circulated and highly addictive. Prime Minister Wong recently announced that the government will treat e-cigarettes as a drug issue, stepping up enforcement and education. E-cigarettes containing etomidate, also known as "zombie pods," pose serious health risks, including nausea, muscle spasms, and even death.

 

Once classified as a Class C drug, users will undergo mandatory supervision and rehabilitation. Repeat offenders may face prosecution and a minimum one-year jail term. Sellers, distributors, and importers may face up to 20 years in prison and caning. Currently, etomidate is regulated under the Poisons Act, with no mandatory rehabilitation or criminal liability for users.

 

Under Section 59 of the Misuse of Drugs Act, the home minister can amend the first, third, fourth, and fifth schedules via gazette, without parliamentary debate. Other Class C drugs include benzphetamine, mephentermine, and nimetazepam.

 

To prevent e-cigarettes from entering the country, Singapore's checkpoints have intensified enforcement. In five days, 184 cases involving e-cigarettes were detected, with over 850 e-cigarettes and accessories seized.

 

Local tour guide Chen Lizhen said that before tourists enter Singapore, she will communicate with the group leaders to remind them of Singapore's entry regulations, especially regarding e-cigarettes and smuggled cigarettes. Upon arrival in Singapore, she will also remind tourists again to ensure they understand the local laws.

 

Dallas Travel Agency pointed out that there is already a set procedure to notify foreign tourists in advance that they are not allowed to bring e-cigarettes into the country. The company then also clearly informed tourists that bringing e-cigarettes would face serious penalties.

 

Super Travel Group Vice President and Marketing Director Huang Haixiao said: "We don't think this will affect inbound tourism because everyone knows that Singapore is a disciplined country, and our previous bans on drugs and chewing gum have not affected Singapore's inbound tourism."

 

O & E Holidays Joint Reviewer Huang Yaoxiong believes that this regulation can help Singapore build a cleaner and safer tourist destination and attract more families to travel to Singapore.

 

Experts pointed out that some tourists may think that smoking e-cigarettes is not serious, but once they are informed that they will face serious penalties, their attitudes will also change.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
PMI Global Communications Chief Moira Gilchrist: Why AI Matters More Than Ever in the Smoke-Free Transition
Philip Morris International (PMI) Chief Global Communications Officer Moira Gilchrist said artificial intelligence is changing how companies understand audiences, manage owned information channels and communicate business transformation. PMI is using AI-generated audience personas to test messaging while optimizing its corporate website and other owned channels for large language models. As PMI continues its transition from cigarettes toward smoke-free products, Gilchrist said owned data and corporate channels are becoming increasingly important in demonstrating the scale of that transformation.
Aug.26
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
Juul Sublicense Reshapes Vuse Alto Patent Bill as Court Ends R.J. Reynolds’ 5.25% Royalty Obligation to Altria
According to Law360 on August 31, 2026, a federal judge in North Carolina ruled that a patent sublicense between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to continue paying royalties to Altria Client Services LLC over Vuse Alto. A jury had previously found that Vuse Alto infringed three Altria patents and awarded approximately $95.2 million in past damages, after which Reynolds was ordered to pay an ongoing royalty equal to 5.25% of positive net sales. The new ruling finds that a valid sublicense can eliminate future infringement, potentially ending what Altria described as hundreds of millions of dollars in future royalties.
Sep.01
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine Raises Excise Stamp Fees for Tobacco, Heated Tobacco and Vape Liquids by 30.5% as Parliament Backs E-Excise Delay to 2027
Ukraine's Cabinet of Ministers adopted Resolution No. 1259 on October 15, 2026, increasing excise stamp production fees for tobacco products and e-cigarette liquids by approximately 30.5%, from UAH 0.1643 to UAH 0.2144 per stamp. Fees for alcoholic beverages rose by about 30.2%. Separately, Ukraine's parliament passed Bill No. 15532 on October 13, proposing to postpone the full implementation of electronic excise stamps and traceability for alcohol, tobacco and e-cigarette liquids from November 1, 2026, to July 1, 2027. Parliament cited additional testing, configuration and integration requirements. The bill was sent to the president for signature on October 19.
Regulations
Oct.21